M04AA01 - Allopurinol |
Probably not porphyrinogenic |
PNP |
Rationale
Pyrimidine derivative. No data pointing to clinically significant CYP-induction. One reference consider it safe and one unsafe.
Chemical description
Tablets; 100-600 mg/d. Pyrazolopyrimidine. Used in gout where it blocks the enzyme xantine oxidase, thus decreasing plasma levels of uric acid. Rapidly metabolized to oxypyrinol (alloxantine) and other metabolites.
Personal communication
Andersson C, patient reports: tolerated (n=3).
IPNet drug reports
Uneventful use reported in 21 patients with acute porphyria.
Similar drugs
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | French List
Centre Français des Porphyries
|
|
| 2. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames